XML 59 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Option And Stock Award Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary Of Stock Options Outstanding summary of stock options outstanding at December 31, 2022, 2021 and 2020, and changes during those years, is presented below:
  Option Exercise Price/Share
  Number of
Options
RangeWeighted
Average
Outstanding at January 1, 20201,628,903 $15.65 to$24.84 $19.13 
Granted638,074 10.75 to14.62 11.90 
Modification for special cash dividend(a)
701,535 10.75 to14.62 11.90 
Forfeited and expired(a)
(141,074)10.75 to24.84 11.87 
Outstanding at December 31, 2020(a)
2,827,438 10.75 to22.49 13.55 
Granted388,822 16.37 to16.37 16.37 
Forfeited and expired(22,611)14.47 to19.64 18.14 
Exercised(67,705)10.75 to17.29 13.51 
Outstanding at December 31, 2021
3,125,944 10.75 to22.49 13.82 
Forfeited and expired(17,203)14.47 to19.64 15.33 
Outstanding at December 31, 20223,108,741 $10.75 to$22.49 $13.81 
(a) The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification due to the anti-dilution provisions in the stock-based compensation plan.
Summary Of Additional Information On Stock Options Outstanding And Exercisable
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2022:
 Options Outstanding at December 31, 2022Options Exercisable at December 31, 2022
  Weighted AverageAggregate Intrinsic Value  Aggregate Intrinsic Value
Range of
Exercise Prices
SharesRemaining Contractual LifeExercise
Price
SharesWeighted Average Exercise Price
$10.75 to$16.37 2,939,509 3.4 years$13.47 $— 2,550,687 $13.03 $— 
17.29 to25.94 169,232 0.7 years19.74 — 169,232 19.74 — 
Total3,108,741 3.3 years$13.82 $— 2,719,919 $13.45 $— 
Summary Of Additional Information On Non-Vested Restricted Stock Outstanding The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2022, 2021 and 2020:
 Unvested Restricted StockMaximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
 Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Outstanding at January 1, 2020285,935 $18.27 $5,224 147,663 $21.25 $3,138 
Granted155,138 14.55 2,257 34,275 15.25 523 
Vested(148,709)17.39 (2,586)(37,370)17.38 (649)
Forfeited(57,385)17.00 (976)(32,066)17.36 (557)
Outstanding at December 31, 2020234,979 16.68 3,919 112,502 21.82 2,455 
Granted200,073 15.63 3,127 14,669 15.24 224 
Vested(87,636)15.78 (1,383)(73,930)17.17 (1,269)
Forfeited(11,616)16.38 (190)(2,523)17.63 (44)
Outstanding at December 31, 2021335,800 16.30 5,473 50,718 17.63 1,366 
Granted301,969 11.88 3,587    
Vested(144,317)15.10 (2,179)   
Forfeited(18,474)14.94 (276)(50,718)17.63 1,366 
Outstanding at December 31, 2022474,978 $13.82 $6,564  $ $ 
Share-based Payment Arrangement, Stock Appreciation Right, Activity
A summary of SARs outstanding at December 31, 2022, 2021 and 2020, and changes during those years, is presented below:
  Exercise Price/Share
  Number of
SARs
RangeWeighted
Average
Outstanding at January 1, 2020— $— to$— $— 
Granted(a)
387,252 10.75 to19.64 11.60 
Modification for special cash dividend71,402 10.75 to19.64 11.60 
Forfeited and expired(82,214)10.75 to19.64 11.39 
Outstanding at December 31, 2020376,440 10.75 to19.64 11.64 
Granted164,464 16.37 to16.37 16.37 
Forfeited and expired(10,043)10.75 to16.37 13.01 
Exercised(9,260)10.75 to15.25 13.87 
Outstanding at December 31, 2021521,601 10.75 to16.37 13.55 
Forfeited and expired(22,914)10.75 to16.37 14.83 
Outstanding at December 31, 2022498,687 $10.75 to$16.37 $13.49 
(a) The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the awards pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements.